GPT and metabolic dysfunction-associated steatotic liver disease: The largest population-based studies used liver enzymes such as aminotransferase (ALT) or GGT as surrogate markers of NAFLD [21–23], and other study assessed ultrasound-diagnosed NAFLD as determinant of NOD [24].